
Am J Psychiatry 159:456-459, March 2002
© 2002 American Psychiatric Association
Low Testosterone Levels in Elderly Men With Dysthymic Disorder
Stuart N. Seidman, M.D.,
Andre B. Araujo, M.A.,
Steven P. Roose, M.D.,
D.P. Devanand, M.D.,
Shan Xie, Ph.D.,
Thomas B. Cooper, M.A., and
John B. McKinlay, Ph.D.
OBJECTIVE: A decline in hypothalamic-pituitary-gonadal (HPG) axis function is often seen in elderly men, and dysthymic disorder is common. Symptoms of both HPG axis hypofunction and dysthymic disorder include dysphoria, fatigue, and low libido. The authors compared total testosterone levels in three groups of elderly men. METHOD: Total testosterone levels were measured in subjects who met DSM-IV criteria for major depressive disorder (N=13) or dysthymic disorder (N=32) and a comparison group (N=175) who had participated in an epidemiological study of male aging and had scored below the median on the Center for Epidemiologic Studies Depression Scale, a well-validated, self-report depression symptom inventory. RESULTS: There were no differences among the three groups in measured demographic variables, including age and weight. Median testosterone levels varied for those with dysthymic disorder (295 ng/dl), major depressive disorder (425 ng/dl), and no depression (423 ng/dl). A test for differences in central tendency showed a statistically significant difference among the three groups. Post hoc pairwise comparisons revealed statistically significant differences between those with dysthymic disorder and those with major depressive disorder and no depression. CONCLUSIONS: Total testosterone levels were lower in elderly men with dysthymic disorder than in men with major depressive disorder and men without depressive symptoms. Dysthymic disorder in elderly men may be related to HPG axis hypofunction.
This article has been cited by other articles:

|
 |

|
 |
 
M Ebinger, C Sievers, D Ivan, H. Schneider, and G. Stalla
Is there a neuroendocrinological rationale for testosterone as a therapeutic option in depression?
J Psychopharmacol,
September 1, 2009;
23(7):
841 - 853.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
O. P. Almeida, B. B. Yeap, G. J. Hankey, K. Jamrozik, and L. Flicker
Low Free Testosterone Concentration as a Potentially Treatable Cause of Depressive Symptoms in Older Men
Arch Gen Psychiatry,
March 1, 2008;
65(3):
283 - 289.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. M. Shores, K. L. Sloan, A. M. Matsumoto, V. M. Moceri, B. Felker, and D. R. Kivlahan
Increased Incidence of Diagnosed Depressive Illness in Hypogonadal Older Men
Arch Gen Psychiatry,
February 1, 2004;
61(2):
162 - 167.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. G. Blazer
Depression in Late Life: Review and Commentary
J. Gerontol. A Biol. Sci. Med. Sci.,
March 1, 2003;
58(3):
M249 - 265.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. G. Pope Jr., G. H. Cohane, G. Kanayama, A. J. Siegel, and J. I. Hudson
Testosterone Gel Supplementation for Men With Refractory Depression: A Randomized, Placebo-Controlled Trial
Am J Psychiatry,
January 1, 2003;
160(1):
105 - 111.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Get information about faster international access.
a>
Privacy Policy
Copyright © 2002
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|